$ABUS I dont understand the ABUS vs. MRNA ideology here. This is not a zero sum game. ABUS badly needs for MRNA to not only produce a working vaccine but to be able to attain a market share. The only time a patent owner can have a monetary claim against patent infringement is when the infringing party has monitized the the unlicensed technology. It is debatable if government funds can be consider monetization, if so this is good news for ABUS bulls. Without MRNA future sales revenue ABUS will be just another patent owner. I am extremely bullish on ABUS, but with MRNA's success as the caveat.
  • 12
12 Likes